Akebia Therapeutics

176 articles with Akebia Therapeutics

• Akebia Licenses Portfolio Of Novel HIF Compounds From Johnson & Johnson Innovation

  2/13/2017

• Akebia Forges $1B U.S. Deal with Otsuka Pharma on Late-Stage Drug

  12/20/2016

• Akebia Prevails in Additional European Patent Dispute

  12/12/2016

• Akebia Announces Third Quarter 2016 Financial Results

  11/10/2016

• Akebia Announces Publication Highlighting Potential Benefits Of HIF Treatments For Patients With Renal Anemia

  9/26/2016

• Akebia Announces Publication Of Phase IIb Data For Vadadustat In Non-Dialysis Patients With Anemia Related To Chronic Kidney Disease

  9/19/2016

• Akebia To Present At Upcoming Investor Conferences

  9/7/2016

• Akebia Announces Publication Highlighting Need For New Solutions In Treating Dialysis Patients

  8/22/2016

• Akebia Initiates INNO2VATE Phase 3 Program For Vadadustat In Dialysis Patients With Anemia Related To Chronic Kidney Disease

  8/9/2016

• Akebia Announces Second Quarter 2016 Financial Results

  8/9/2016

• Akebia Appoints Scott A. Canute To Its Board Of Directors

  8/3/2016

• Akebia To Present At The Cantor Fitzgerald Annual Healthcare Conference

  7/6/2016

• Akebia Announces Positive Vadadustat Data Demonstrating No Clinically Significant Drug-Drug Interaction

  5/23/2016

• Akebia To Present At The 2016 UBS Global Healthcare Conference

  5/16/2016

• Akebia Announces First Quarter 2016 Financial Results And Provides Corporate Update

  5/6/2016

• Akebia Announces Presentation Of Vadadustat Phase 2 Dialysis Data At Upcoming National Kidney Foundation 2016 Spring Clinical Meetings

  4/26/2016

• Akebia To Present At The 15th Annual Needham Healthcare Conference

  4/5/2016

• Akebia Announces Fourth Quarter And Full-Year 2015 Financial Results

  3/15/2016

• Akebia To Host Conference Call On March 14th To Discuss Full-Year 2015 Financial Results And Corporate Highlights

  3/9/2016

• Akebia Prevails In European Patent Dispute And Preserves Access To Key Market For Vadadustat

  3/9/2016